General Information of Drug (ID: DM20X8C)

Drug Name
5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine Drug Info
Synonyms
CHEMBL1163059; 1pfy; AC1L9LA4; SCHEMBL4308351; BDBM50222901; 5'-O-[N-(L-Methionyl)-sulfamoyl]adenosine; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-[(2S)-2-amino-4-methylsulfanylbutanoyl]sulfamate
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
46936326
TTD Drug ID
DM20X8C

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
REP8839 DMZJH23 Bacterial infection 1A00-1C4Z Phase 1 [2]
Difluoromethionine DM8TG41 Discovery agent N.A. Investigative [1]
Methionine Phosphonate DMOUTNA Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Streptococcus Methionyl-tRNA synthetase (Stre-coc metG) TTOJ46K SYM_STRP1 Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 Antibacterial activity of REP8839, a new antibiotic for topical use. Antimicrob Agents Chemother. 2005 Oct;49(10):4247-52.